Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 32 | ECE2013 | Next issue

15th European Congress of Endocrinology

Poster Presentations

Bone and Osteoporosis

Previous section
Adrenal Medulla
Table of contents
Next section
Calcium and Vitamin D metabolism

ea0032p70 | Bone and Osteoporosis

Bone loss in inflammation-mediated osteoporosis: a role for the P2×7 receptor?

ea0032p71 | Bone and Osteoporosis

Abstract unavailable

ea0032p72 | Bone and Osteoporosis

Circadian rhythm of circulating sclerostin in healthy young men

ea0032p73 | Bone and Osteoporosis

Cross-correlation of circulating sclerostin over 24 h to PTH, phosphate and bone markers in healthy young men

ea0032p74 | Bone and Osteoporosis

Bone quality, as measured by trabecular bone score (TBS), in patients with primary hyperparathyroidism

ea0032p75 | Bone and Osteoporosis

Calcium homeostasis in women with non-metastatic breast cancer with osteoporosis after a single-dose of denosumab: a pilot study

ea0032p76 | Bone and Osteoporosis

Long-term prospective evaluation of the effects of estroprogestagen therapy on the bone mineral density of girls with Turner syndrome carrying various PvuII AND XbaI polymorphisms of ER-α

ea0032p77 | Bone and Osteoporosis

Cathepsin K secretion in human primary osteoblastic cell cultures and its influence by different glucose concentrations

ea0032p78 | Bone and Osteoporosis

Effects of Denosumab treatment on insulin resistance in postmenopausal women with osteoporosis

ea0032p79 | Bone and Osteoporosis

Impact of the FRAX® tool and the NOGG guidelines on the indication of bone mineral density in Spanish postmenopausal women

ea0032p80 | Bone and Osteoporosis

Increased IL17A serum levels associated with low estrogen levels can play a role in postmenopausal osteoporosis

ea0032p81 | Bone and Osteoporosis

Effects of the tamoxifen on calcitonin producing thyroid C cells and bone in rat model of male osteoporosis

ea0032p82 | Bone and Osteoporosis

The value of PRP/PRF in the treatment of bisphosphonates-induced maxillary osteonecrosis: preliminary study

ea0032p83 | Bone and Osteoporosis

Bone mineral density in patients with hypersomatotropism

ea0032p84 | Bone and Osteoporosis

Effects of treatment for acromegaly on bone mineral density: is pegvisomant protective on lumbar BMD?

ea0032p85 | Bone and Osteoporosis

HLA class I, Cw*01 and Cw*15 alleles can play a preventing role in serum IL17 elevation associated with postmenopausal osteoporosis in Hungary

ea0032p86 | Bone and Osteoporosis

Bone health in type 1 diabetes patients with celiac disease

ea0032p87 | Bone and Osteoporosis

Oxidative stress in middle age males with osteoporosis: correlation of hormonal pattern and plasma total antioxidant capacity

ea0032p88 | Bone and Osteoporosis

Lean body mass and leptin, but not fat mass are independent predictors of bone mass in postmenopausal women

ea0032p89 | Bone and Osteoporosis

Association of the (TTTA)n repeat polymorphism of CYP19 gene with bone mineral density in Greek peri- and postmenopausal women

ea0032p90 | Bone and Osteoporosis

Vitamin D receptor polymorphisms and bone mass indices in post menarcheal indian adolescent girls

ea0032p91 | Bone and Osteoporosis

Bone health in children with GH deficiency

ea0032p92 | Bone and Osteoporosis

The effect of monthly Ibandronate on bone mineral density and bone turnover markers in patients with hemophilia A or B and increased risk for fracture

ea0032p93 | Bone and Osteoporosis

Age overlooked as a risk factors for osteoporosis

ea0032p94 | Bone and Osteoporosis

Trabecular bone score and bone mineral density in Ukrainian normal women depending on duration of postmenopausal period

ea0032p95 | Bone and Osteoporosis

Bone metabolism with special emphasis to osteoprotegerin and vitamin D3 concentrations in premenopausal women with thyroid dysfunction

ea0032p96 | Bone and Osteoporosis

Efficacy and safety of monthly oral minodronate for the treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients

ea0032p97 | Bone and Osteoporosis

Change in bone mass in patients with established hyperthyroidism

ea0032p98 | Bone and Osteoporosis

The follow-up in patients evaluated based on quantitative ultrasound: a prospective study

ea0032p99 | Bone and Osteoporosis

Prospective study of bone mineral density in girls treated with estroprogestagens for functional hypothalamic amenorrhea during late puberty in relation to the polymorphism of VDR (BsmI), ER (PvuII; Xba I), and COLIA1 genes

ea0032p100 | Bone and Osteoporosis

Vertebral fracture prevalence in postmenopausal women in relation to bone mineral density (BMD)

ea0032p101 | Bone and Osteoporosis

Vertebral fractures in women with postmenopausal osteoporosis with or without prior fragile fracture

ea0032p102 | Bone and Osteoporosis

Effect of long-term valproate therapy on bone health parameters

ea0032p103 | Bone and Osteoporosis

Efficacy and safety of the anabolic therapies in severe osteoporosis: experience of a team of endocrinologists and spine surgeons

ea0032p104 | Bone and Osteoporosis

Vitamin D receptor, BsmI, FokI, ApaI, TaqI and estrogen receptor alpha, PvuII and XbaI, gene polymorphisms in women with osteoporosis

ea0032p105 | Bone and Osteoporosis

Possible benefits of PTH 1–84 therapy in pregnancy and lactation osteoporosis (PLO)

ea0032p106 | Bone and Osteoporosis

Influence of some traditional risk factors for osteoporosis on bone metabolism during substitution therapy of primary hypothyroidism

ea0032p107 | Bone and Osteoporosis

Resolution of anaemia after curative parathyroidectomy in a patient with primary hyperparathyroidism

ea0032p108 | Bone and Osteoporosis

A case of 23 years old woman with primary hyperparathyroidism presenting with pathological fracture and brown tumors detected by scintigraphy

ea0032p109 | Bone and Osteoporosis

A patient osteogenesis imperfecta with osteoporosis

ea0032p110 | Bone and Osteoporosis

Fear of illness and quality of life in Greek postmenopausal women with osteoporosis

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more